STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
NCT ID: NCT00252824
Last Updated: 2011-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1000 participants
INTERVENTIONAL
2005-07-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma
NCT00628758
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
NCT00290264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed daily use of glucocorticosteroids at a dose \> 320 mcg/ day for at least 3 months prior to Visit 1
Exclusion Criteria
* Asthma exacerbation requiring change in asthma treatment during the last 14 days prior to inclusion
* Any significant disease or disorder that my jeopardize the safety of the patient.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca Symbicort Medical Science Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Quillota, , Chile
Research Site
Valparaíso, , Chile
Researh Site
Dubrovnik, , Croatia
Research Site
Split, , Croatia
Research Site
Zagreb, , Croatia
Research Site
Brno, , Czechia
Research Site
Hradec Králové, , Czechia
Research Site
Jihlava, , Czechia
Research Site
Litomice, , Czechia
Research Site
Ostrava, , Czechia
Research Site
Prague, , Czechia
Research Site
Prostijov, , Czechia
Research Site
Strakonice, , Czechia
Research Site
Ahens, , Greece
Research Site
Alexandroup, , Greece
Research Site
Athens, , Greece
Research Site
Kavala, , Greece
Research Site
Akureyri, , Iceland
Research Site
Reykjavik, , Iceland
Research Site
Daugavpils, , Latvia
Research Site
Riga, , Latvia
Research Site
Rigas Raj, , Latvia
Research Site
Kaunas, , Lithuania
Research Site
Klaipėda, , Lithuania
Research Site
Vilnius, , Lithuania
Research Site
Aveiro, , Portugal
Research Site
Coimbra, , Portugal
Research Site
Coviha, , Portugal
Research Site
Lisbon, , Portugal
Research Site
Porto, , Portugal
Research Site
Setúbal, , Portugal
Research Site
Vila Nova de Gaia, , Portugal
Research Site
Banská Bystrica, , Slovakia
Research Site
Bardejov, , Slovakia
Research Site
Bratislava, , Slovakia
Research Site
Hlohovec, , Slovakia
Research Site
Košice, , Slovakia
Research Site
Liptovský Hrádok, , Slovakia
Research Site
Malacky, , Slovakia
Research Site
Nitra Zobor, , Slovakia
Research Site
Partizánske, , Slovakia
Research Site
Revúca, , Slovakia
Research Site
Senec, , Slovakia
Research Site
Topostany, , Slovakia
Research Site
Žilina, , Slovakia
Research Site
Celje, , Slovenia
Research Site
Golnik, , Slovenia
Research Site
Kamnik, , Slovenia
Research Site
Koper, , Slovenia
Research Site
Litija, , Slovenia
Research Site
Ljubljana, , Slovenia
Research Site
Murska Sobota, , Slovenia
Research Site
Nova Gorica, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STYLE
Identifier Type: -
Identifier Source: secondary_id
D5890L00014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.